Flagship explainer

How STANDARD BIOTOOLS INC. makes its money

Start with a dollar of revenue and follow what the filing says remains.

revenueBranching filed flows with values and percentages directly labeled. Missing filing concepts are omitted rather than estimated.Revenue$85.3M · 100%Cost of revenue$42.8M · 50%Gross profit$42.5M · 50%Operating income−$110M · −129%Income before tax−$96.7M · −113%Income tax−$37.9M · −44%Net income−$74.9M · −88%As of 2025-12-31 · 1 SEC filing sourceBuy Like Buffett · buylikebuffett.com

Honest partial: the filing did not provide a normalized tag for Research and development, Selling, general and administrative; those components are omitted, not plugged.

Table alternative
Filed lineValue% of revenueSource
$85.3M100%
Cost of revenue$42.8M50%
$42.5M50%
−$110M−129%
Income before tax−$96.7M−113%
Income tax−$37.9M−44%
−$74.9M−88%
Source: · event Dec 31, 2025 · retrieved Jul 26, 2026 · annual-row source set
Embed this chart

View the full STANDARD BIOTOOLS INC. analysis at Buy Like Buffett